<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04019691</url>
  </required_header>
  <id_info>
    <org_study_id>SMC 2019-06-017-001</org_study_id>
    <nct_id>NCT04019691</nct_id>
  </id_info>
  <brief_title>Comparing the Visual Outcome, Visual Quality, and Satisfaction Among Three Types of Multi-focal Intraocular Lenses</brief_title>
  <official_title>Comparing the Visual Outcome, Visual Quality, and Satisfaction Among Three Types of Multi-focal Intraocular Lenses</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Samsung Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Samsung Medical Center</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators are going to Investigate the comparative efficacy of the patients who
      underwent cataract surgery with three diffirent multifocal IOLs.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Going to analyze the clinical results of 60 patients who underwent bilateral cataract surgery
      and multifocal IOL implantation. The patients were divided into the following three groups:
      Mix-and-Match, EDOF, and Trifocal. The clinical assessments included uncorrected near,
      intermediate, distance and best corrected distance visual acuity, defocus curves, contrast
      sensitivity, and reading speed. Patient satisfaction was evaluated by questionnaire. All
      outcomes were compared among the three groups.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">August 1, 2017</start_date>
  <completion_date type="Anticipated">September 30, 2019</completion_date>
  <primary_completion_date type="Anticipated">August 30, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Postoperative uncorrected near, intermediate, and far visual acuity.</measure>
    <time_frame>At 1month and 3months after surgery</time_frame>
    <description>logMAR</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Postoperative contrast sensitivity in the three groups.</measure>
    <time_frame>Postoperative 3 months</time_frame>
    <description>3, 6, 12, and 18 cycles per degree using a CSV-1000 chart (Vector Vision, reenville, OH) under photopic (85 cd/m2), mesopic (~3 cd/m2), and mesopic with glare conditions</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Postoperative satisfaction questionnaire.</measure>
    <time_frame>Postoperative 3 months</time_frame>
    <description>patients were shown images and asked to rate the frequency, degree, and discomfort related to the visual artifacts as none, minimal, moderate, or severe (0, 1, 2, or 3 points for the respective levels). The mean score was calculated.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postoperative refractive outcome</measure>
    <time_frame>Postoperative 3 months</time_frame>
    <description>Diopter</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Cataract</condition>
  <arm_group>
    <arm_group_label>Mix-and-Match group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Cataract surgery and implantation of a Tecnis ZKB00 multifocal IOL with +2.75 D add power (Abbott Medical Optic Inc., Santa Ana, CA) in the dominant eye, and a Tecnis ZLB00 multifocal IOL with +3.25 D add power (Abbott Medical Optics Inc.) in the non-dominant eye.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>EDOF group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Cataract surgery and implantation of Tecnis Symfony ZXR00 trifocal IOLs (Abbot Medical Optics Inc.) in both eyes.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Trifocal group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Cataract surgery and implantation of FineVision PodFT IOLs (PhysIOL SA) in both eyes.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Mix-and-Match</intervention_name>
    <description>Phacoemulsification and implantation of Tecnis ZKB00 multifocal IOL with +2.75 D add power (Abbott Medical Optic Inc., Santa Ana, CA) in the dominant eye, and a Tecnis ZLB00 multifocal IOL with +3.25 D add power (Abbott Medical Optics Inc.) in the non-dominant eye.</description>
    <arm_group_label>Mix-and-Match group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>EDOF</intervention_name>
    <description>Phacoemulsification and implantation of Tecnis Symfony ZXR00 trifocal IOLs (Abbot Medical Optics Inc.) in both eyes.</description>
    <arm_group_label>EDOF group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Trifocal</intervention_name>
    <description>Phacoemulsification and implantation of FineVision PodFT IOLs (PhysIOL SA) in both eyes.</description>
    <arm_group_label>Trifocal group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with bilateral senile cataracts and the desire to be spectacle-free for all
             distances

        Exclusion Criteria:

          -  Patients younger than 21 years, had corneal astigmatism &gt;1.00 D, previous ocular
             surgery or trauma, or ocular disease other than cataracts
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Samsung Medical Center</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>July 10, 2019</study_first_submitted>
  <study_first_submitted_qc>July 12, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 15, 2019</study_first_posted>
  <last_update_submitted>July 15, 2019</last_update_submitted>
  <last_update_submitted_qc>July 15, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 17, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>multifocal intraocular lens</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cataract</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

